Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis

INTRODUCTION: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA), and is being investigated for the treatment of psoriasis. Both conditions can present in women of child-bearing potential, but pregnancy was an exclusion and discontinuation criterion in tofac...

Descripción completa

Detalles Bibliográficos
Autores principales: Clowse, Megan E. B., Feldman, Steven R., Isaacs, John D., Kimball, Alexandra B., Strand, Vibeke, Warren, Richard B., Xibillé, Daniel, Chen, Yan, Frazier, Donald, Geier, Jamie, Proulx, James, Marren, Amy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933738/
https://www.ncbi.nlm.nih.gov/pubmed/27282428
http://dx.doi.org/10.1007/s40264-016-0431-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933738/
https://www.ncbi.nlm.nih.gov/pubmed/27282428
http://dx.doi.org/10.1007/s40264-016-0431-z

Ejemplares similares